000 01561 a2200469 4500
005 20250518015842.0
264 0 _c20190708
008 201907s 0 0 eng d
022 _a1873-1449
024 7 _a10.1016/j.brachy.2018.12.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKing, Martin T
245 0 0 _aA comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.
_h[electronic resource]
260 _bBrachytherapy
_c
300 _a186-191 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBrachytherapy
_xmethods
650 0 4 _aDatabases, Factual
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProgression-Free Survival
650 0 4 _aProportional Hazards Models
650 0 4 _aProstatic Neoplasms
_xradiotherapy
650 0 4 _aRadiotherapy Dosage
650 0 4 _aRisk Factors
650 0 4 _aSurvival Rate
700 1 _aYang, David D
700 1 _aMuralidhar, Vinayak
700 1 _aMahal, Brandon
700 1 _aButler, Santino
700 1 _aDevlin, Phillip M
700 1 _aLee, Larissa J
700 1 _aMouw, Kent W
700 1 _aMartin, Neil M
700 1 _aD'Amico, Anthony V
700 1 _aNguyen, Paul L
700 1 _aOrio, Peter F
773 0 _tBrachytherapy
_gvol. 18
_gno. 2
_gp. 186-191
856 4 0 _uhttps://doi.org/10.1016/j.brachy.2018.12.007
_zAvailable from publisher's website
999 _c29250028
_d29250028